News > Capital Markets, FinTech

Andrew Left Goes Long Fitbit, Sees 130% Upside

By BenZinga
Capital Markets, FinTech

Fitbit Inc (NYSE: FIT) was already on the rise Monday when Citron Research came out with a bullish report touting Fitbit as one of the best medtech companies in the industry and forecasting 130-percent upside.

“What was once a piñata for short-sellers (since IPO) has transformed itself to one of the most underappreciated med-tech stories in the market with a balance sheet and brand equity that gives investors a tremendous investing opportunity,” Citron’s Andrew Left wrote in a report.

Left predicted Fitbit will either strike $15 or be …

Read the full story at Benzinga.

Subscribe to our Newsletter

Be one of the first to experience the future of financial services